MASHINIi

Adagio Medical Holdings, Inc.

ADGM.US | Manufacture of medical and dental instruments and supplies

Adagio Medical Holdings, Inc. is a medical technology company focused on developing and commercializing innovative cardiac ablation technologies for the treatment of atrial fibrillation (Afib). Their primary product is the iCLAS catheter, which uses pulsed field cryoablation (PFCA) technology to cre...Show More

Ethical Profile

Mixed.

Adagio Medical Holdings, Inc. (ADGM.US) faces questions regarding its business practices, with reports revealing a financial misstatement disclosed in November 2024. The company also received a Nasdaq notice in January 2025 for alleged non-compliance with audit committee requirements due to a vacancy, with a cure period set until June 2025. These issues have been linked to weaknesses in financial oversight and governance. Despite these concerns, Adagio's core business is dedicated to developing ablation technologies for cardiac arrhythmias, a mission fundamentally supportive of improving global health outcomes.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-20
-100100
Kind to Animals-40
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Adagio Medical Holdings, Inc on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Adagio Medical Holdings, Inc on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No relevant data was found in the provided article to assess Adagio Medical Holdings, Inc. against the 'Fair Pay & Worker Respect' ethical value.

1
The Glassdoor page referenced was unavailable or did not contain extractable information for any of the specified KPIs.
2

Fair Trade & Ethical Sourcing

0

No evidence available to assess Adagio Medical Holdings, Inc on Fair Trade & Ethical Sourcing.

Honest & Fair Business

-20

The company disclosed one financial misstatement in a Form 8-K on November 1, 2024.

1
Additionally, it received a notice from Nasdaq on January 2, 2025, regarding non-compliance with Nasdaq's audit committee requirements due to a vacancy, with a cure period provided until the earlier of the company’s next annual shareholders’ meeting or January 2, 2026, or June 30, 2025.
2

Kind to Animals

-40

The company conducts animal testing for medical analysis and clinical research, explicitly stating they "exploit animals for product testing" in pre-clinical investigations.

1
This indicates a policy that permits animal testing, without any evidence of restrictions, reduction commitments, or the use of alternatives.

No War, No Weapons

0

No evidence available to assess Adagio Medical Holdings, Inc on No War, No Weapons.

Planet-Friendly Business

0

No evidence was found in the provided articles regarding Adagio Medical Holdings, Inc.'s performance on any of the Planet-Friendly Business KPIs. The articles discuss strategic restructuring, a pause in a product launch, and a reduction in force, but do not contain information on environmental performance, targets, or initiatives.

1

Respect for Cultures & Communities

0

No evidence available to assess Adagio Medical Holdings, Inc on Respect for Cultures & Communities.

Safe & Smart Tech

0

No specific, concrete evidence was found in the provided articles regarding ADGM.US's performance or policies related to data protection, cybersecurity, or responsible AI. The articles discuss general ethical considerations for AI in healthcare and a product-specific FDA Breakthrough Device Designation for Adagio Medical Holdings' vCLAS Cryoablation System, but do not provide company-specific data for any of the Safe & Smart Tech KPIs.

1

Zero Waste & Sustainable Products

0

The provided article focuses exclusively on Adagio Medical Holdings' financial data, regulatory actions related to Nasdaq compliance, and product designations.

1
It explicitly states that it does not contain any data relevant to waste management, sustainable products, circular economy principles, waste reduction initiatives, certifications, or industry benchmarks in these areas.
2
Therefore, no KPIs for Zero Waste & Sustainable Products can be scored based on the available evidence.

Own Adagio Medical Holdings, Inc?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.